Helveticann is dedicated to enhancing the public perception of cannabis through the scientifically researched development of consumer CBD products and the creation of trustworthy brands.
We envision a future where cannabis is once again an accepted and valuable component of the pharmacopeia, providing natural treatments for chronic conditions as part of the mainstream medical practitioners’ repertoire.
We strive to not only abide by accepted best practices, but to forge a new path and guide the industry through thought leadership and ethical growing, manufacturing, and business activities.
We remain intensely focused on cultivating consumer trust. Of paramount importance is our ability to provide the highest quality, premium CBD products while delivering the optimal customer experience.
We operate with integrity, follow through with our promises, and strive to be the driving force for disciplined, pragmatic innovation in the evolution of the world’s perception of cannabis therapies.
We are proud to offer
PREMIUM CBD PRODUCTS
Nuance Group AG,
Capital Stroy & Energo Garant
BA, Finance, IFM University
Chief Operating Officer
Development for Miscanthus Group
Founder Energo-Agrar LLC
Consulting for Softengy, Teradata Inc.
MSc, Aviation Electronic Equipment, National Aviation University of Ukraine
Chief Financial Officer
Akras Research & Capital
FlowPoint Capital Partners
Longfellow Investment Management
MSc, Finance, Bentley University
MBA, Bentley University
BA, Saint Anselm College